HighTower Advisors
GSK icon

HighTower Advisors’s GSK GSK Stock Holding History

HighTower Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$40 – 3542
2023
Q1 		$40 Buy
+100
New +$3.5K ﹤0.01% 3388
2022
Q1 		– Sell
-10
Closed -$12K – 3517
2021
Q4 		$12K Buy
+10
New +$520 ﹤0.01% 3147

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HighTower Advisors's GSK Position: Q2 2026 in Review

HighTower Advisors reduced its GSK (GSK) stake by 4.6% in Q2 2026, selling an estimated $304K and leaving 118,260 shares worth $6.2M. The position accounts for 0.01% of the portfolio, ranked #1138.

HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.1M in Q1 2022. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • HighTower Advisors held 118,260 shares of GSK worth $6.2M as of Q2 2026.
  • HighTower Advisors sold 5,742 GSK shares in Q2 2026, an estimated $304K.
  • GSK made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #1138 holding.
  • HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's GSK position peaked at $57.1M in Q1 2022.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.